While results implicate Wnt5a as a potential molecular mediator, additional mechanistic studies are needed to elucidate the mechanosensory receptors and/or pathways that mediate the observed effects and to modulate the activity of these effectors in relevant pre-clinical models of metastatic disease. Here, WNT5A is linked to metastatic neoplasm.